EAGAN, Minn.--(BUSINESS WIRE)--Biothera will present new data to cancer researchers from around the world that expands scientific understanding of how the company’s investigational cancer immunotherapy Imprime PGG® engages both the innate and adaptive immune systems to kill antibody-targeted cancer cells. Biothera has had five research abstracts accepted for presentation at the International Cancer Immunotherapy Conference September 16-19 in New York City.
Help employers find you! Check out all the jobs and post your resume.
